BioCentury | Sep 25, 2020
Management Tracks

Lopes-Fernandes to lead BD for Ipsen; plus

...CFO. A former investment banker, Leiderman was most recently CBO of fibrosis and inflammatory disease company Complexa...
BioCentury | Feb 8, 2020
Management Tracks

Gottlieb joins Illumina’s board; plus Kiniksa, Frequency, DBV, VectivBio and more

...for rare diseases at Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK). Fibrotic and inflammatory disease company Complexa Inc....
...Flexion Therapeutics (NASDAQ:FLXN). Hongjiang Li and Elizabeth S. Eaton, Staff Writers Dyne Therapeutics Inc. Imara Inc. Pharvaris B.V. DBV Technologies S.A. Complexa Inc....
BioCentury | Oct 3, 2019
Product Development

Kidney is the new liver: why kidney indications are coming into sharp focus

...RTA 402, CDDO-Me) in Phase II or Phase III testing for four renal indications, and Complexa Inc....
BioCentury | Jul 23, 2019
Company News

Management tracks: Epizyme, Disarm, Kaleido, Selecta and more

...John Kirby to CFO from VP of finance. Tarka was VP of clinical development at Complexa Inc....
BioCentury | May 14, 2018
Company News

Management tracks: Complexa, Immatics

...Fibrotic and inflammatory disease company Complexa Inc. (Berwyn, Pa.) hired Francisco Salva as president and CEO. He...
BioCentury | Feb 6, 2018
Financial News

EdRIP unveils new €345 million fund

...fund, participating in a $62 million series C round for renal, cardiovascular and hematology company Complexa Inc....
BioCentury | Feb 6, 2018
Finance

Stepping up in Europe

...far, participating in a $62 million series C round for renal, cardiovascular and hematology play Complexa Inc....
BioCentury | Jul 28, 2017
Financial News

NEA, Pfizer back Complexa in $62M series C round

...Rare disease play Complexa Inc. (Pittsburgh, Pa.) raised $62 million on July 26 in a series C...
...HBM Healthcare Investments also participated, as did existing investor JAFCO. Complexa Inc. , Pittsburgh, Pa. Elizabeth S. Eaton Complexa Inc....
BioCentury | Jul 26, 2017
Financial News

NEA, Pfizer back Complexa in $62M series C round

...Rare disease play Complexa Inc. (Pittsburgh, Pa.) raised $62 million in a series C round led by...
...Partners and HBM Healthcare Investments also participated, as did existing investor JAFCO. In early 2018, Complexa...
...led Complexa’s series B financing in 2014 (see BioCentury Extra, June 4, 2014) . Elizabeth S. Eaton CXA-10 Complexa Inc....
BioCentury | Feb 17, 2017
Targets & Mechanisms

Gilding the Goldfinch

...ATGR1) antagonist, and propagermanium, a CC chemokine receptor 2 (CCR2; CD192) antagonist FSGS Phase II Complexa Inc....
Items per page:
1 - 10 of 14
BioCentury | Sep 25, 2020
Management Tracks

Lopes-Fernandes to lead BD for Ipsen; plus

...CFO. A former investment banker, Leiderman was most recently CBO of fibrosis and inflammatory disease company Complexa...
BioCentury | Feb 8, 2020
Management Tracks

Gottlieb joins Illumina’s board; plus Kiniksa, Frequency, DBV, VectivBio and more

...for rare diseases at Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK). Fibrotic and inflammatory disease company Complexa Inc....
...Flexion Therapeutics (NASDAQ:FLXN). Hongjiang Li and Elizabeth S. Eaton, Staff Writers Dyne Therapeutics Inc. Imara Inc. Pharvaris B.V. DBV Technologies S.A. Complexa Inc....
BioCentury | Oct 3, 2019
Product Development

Kidney is the new liver: why kidney indications are coming into sharp focus

...RTA 402, CDDO-Me) in Phase II or Phase III testing for four renal indications, and Complexa Inc....
BioCentury | Jul 23, 2019
Company News

Management tracks: Epizyme, Disarm, Kaleido, Selecta and more

...John Kirby to CFO from VP of finance. Tarka was VP of clinical development at Complexa Inc....
BioCentury | May 14, 2018
Company News

Management tracks: Complexa, Immatics

...Fibrotic and inflammatory disease company Complexa Inc. (Berwyn, Pa.) hired Francisco Salva as president and CEO. He...
BioCentury | Feb 6, 2018
Financial News

EdRIP unveils new €345 million fund

...fund, participating in a $62 million series C round for renal, cardiovascular and hematology company Complexa Inc....
BioCentury | Feb 6, 2018
Finance

Stepping up in Europe

...far, participating in a $62 million series C round for renal, cardiovascular and hematology play Complexa Inc....
BioCentury | Jul 28, 2017
Financial News

NEA, Pfizer back Complexa in $62M series C round

...Rare disease play Complexa Inc. (Pittsburgh, Pa.) raised $62 million on July 26 in a series C...
...HBM Healthcare Investments also participated, as did existing investor JAFCO. Complexa Inc. , Pittsburgh, Pa. Elizabeth S. Eaton Complexa Inc....
BioCentury | Jul 26, 2017
Financial News

NEA, Pfizer back Complexa in $62M series C round

...Rare disease play Complexa Inc. (Pittsburgh, Pa.) raised $62 million in a series C round led by...
...Partners and HBM Healthcare Investments also participated, as did existing investor JAFCO. In early 2018, Complexa...
...led Complexa’s series B financing in 2014 (see BioCentury Extra, June 4, 2014) . Elizabeth S. Eaton CXA-10 Complexa Inc....
BioCentury | Feb 17, 2017
Targets & Mechanisms

Gilding the Goldfinch

...ATGR1) antagonist, and propagermanium, a CC chemokine receptor 2 (CCR2; CD192) antagonist FSGS Phase II Complexa Inc....
Items per page:
1 - 10 of 14